z-logo
Premium
Immortal time bias or sorafenib effect in elderly patients with HCC?
Author(s) -
Sanoff Hanna K.,
Chang YunKyung,
Lund Jennifer L.,
O'Neil Bert H.,
Dusetzina Stacie B.
Publication year - 2017
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.29250
Subject(s) - sorafenib , medicine , hazard ratio , propensity score matching , hepatocellular carcinoma , confidence interval , hepatology , oncology , observational study , population , environmental health
carcinoma in patients carrying the Z allele. While intriguing, the hypothesis raised by Ponzetto et al. remains highly speculative. Although Shimoda et al. found that CagA is present in serum-derived exosomes of patients infected with H. pylori, it is unknown whether these exosomes are released in sufficient amount to be taken up by hepatocytes and efficiently activate the c-Jun N-terminal kinase and c-Jun pathway. Moreover, activation of c-Jun by CagA has been observed in gastric epithelial cells exposed to H. pylori, and whether CagA can activate the c-Jun N-terminal kinase and c-Jun also in hepatocytes has to be shown. Co-occurrence of peptic ulcer by H. pylori has been observed in patients with alpha1-antitrypsin deficiency. However, whether infection with H. pylori is associated with a higher rate of liver disease in patients with alpha1-antitrypsin deficiency has not been investigated so far. In summary, extensive studies both in preclinical models and in the clinic are needed to show whether H. pylori is indeed a modifier of the expressivity of liver disease in alpha1-antitrypsin deficiency.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom